— Know what they know.
Not Investment Advice
Also trades as: VIV.V (TSXV) · $vol 0M

VIVXF OTC

Avivagen Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $7769 mcap · 77M float · 0.0002% daily turnover

Cash Flow Trends

Operating Cash Flow
-$3M +32.2% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$3M +32.4% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$1M -250.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$5M-$5M-$5M-$6M-$6M
Depreciation & Amort.$3K$5K$127K$125K$87K
Stock-Based Comp.$576K$318K$319K$327K$152K
Change in Working Capital-$237K-$2K-$255K-$918K$2M
Other Non-Cash Items$685K$994K$1M$2M$1M
Operating Cash Flow-$4M-$4M-$3M-$5M-$3M
— Investing Activities —
Capital Expenditures-$70K-$109K-$44K-$9K$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$70K-$109K-$44K-$9K$0
— Financing Activities —
Net Debt Issuance$754K$2M$686K-$859K-$1M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$329K$242K-$724K-$1M-$907K
Financing Cash Flow$4M$3M$3M$5M$2M
Net Change in Cash$607K-$1M-$422K$744K-$1M
Cash End of Period$2M$1M$664K$1M$290K
Free Cash Flow-$4M-$4M-$3M-$5M-$3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms